Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|July 19, 2021
Identification and Validation of Immune-Related Methylation Clusters for Predicting Immune Activity and Prognosis in Breast CancerAnli Yang, Ying Zhou, Yanan Kong, et al.
Nanoscale|March 29, 2013
Chemical insight into electroforming of resistive switching manganite heterostructuresFrancesco Borgatti, Chanwoo Park, Anja Herpers, et al.
Frontiers in Pharmacology|October 26, 2020
Cavin3 Suppresses Breast Cancer Metastasis via Inhibiting AKT PathwayXin An, Xi Lin, Anli Yang, et al.
Nucleic Acids Research|November 9, 2025
RM2Target v2.0: an updated database for the target genes of writers, erasers, and readers of RNA modificationsXiaoqiong Bao, Qi Jiang, Weixuan Chen, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 15, 2020
The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRITiebao Meng, Ni He, Haoqiang He, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 7, 2024
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancerYutian Zou, Anli Yang, Bo Chen, et al.
Clinical Proteomics|July 14, 2024
ESF1 and MIPEP proteins promote estrogen receptor-positive breast cancer proliferation and are associated with patient prognosisQing Yu, Chunhua Qu, Jinliang Liang, et al.
Clinical and Translational Medicine|February 11, 2023
Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic studyShaoquan Zheng, Jie-Ying Liang, Yuhui Tang, et al.
Developmental Biology|July 14, 2019
Meg3-DMR, not the Meg3 gene, regulates imprinting of the Dlk1-Dio3 locusWende Zhu, Erin M Botticelli, Rachel E Kery, et al.
Oncoimmunology|January 10, 2022
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancerShaoquan Zheng, Yutian Zou, Yuhui Tang, et al.
Pageof 8